Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI and cap team up to spot hidden colon polyps

NCT ID NCT05594576

Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using an artificial intelligence system (GI GENIUS) together with a special cap (ENDOCUFF VISION) on the colonoscope helps doctors find more precancerous polyps during colonoscopy than using either tool alone. About 481 adults undergoing screening or follow-up colonoscopy took part. The goal was to see if the combination improves detection of adenomas, which are early warning signs for colorectal cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

481 people

The number who actually took part.

Started

Oct 2022

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Need to perform colorectal cancer screening colonoscopy: * Primary Screening: Fecal Immunological Test positive; * Secondary screening: personal or family history of polyps, personal or family history of colorectal cancer, rectorrhagia-like symptomatology. * Patient candidate for outpatient management. * Patient who has given free and informed consent. * Patient who has signed the consent form. * Patient affiliated or beneficiary of a health insurance plan. Exclusion Criteria: * The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * History of inflammatory bowel disease, Crohn's disease. * Failure of a previous colonoscopy. * Known familial polyposis. * Contraindication to polypectomy (coagulation disorder, treatment with CLOPIDOGREL / anticoagulant).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenoma colon adenoma colorectal cancer colorectal neoplasm intestinal polyp

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenoma Colorectal cancer Intestinal polyps

Contacts and locations

Locations

  • CHU de Limoges

    Limoges, 87000, France

  • CHU de Nîmes

    Nîmes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.